» Authors » Christopher D Jensen

Christopher D Jensen

Explore the profile of Christopher D Jensen including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 72
Citations 2518
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Langevin M, Jensen C, Marks A, Merchant S, Badalov J, Lee J, et al.
Am J Gastroenterol . 2025 Jan; PMID: 39760381
Introduction: The COVID-19 pandemic reduced colorectal cancer (CRC) screening, but the rebound in testing and outcomes after the pandemic has not been widely reported. We evaluated CRC test utilization and...
2.
Harlass M, Dalmat R, Chubak J, van den Puttelaar R, Udaltsova N, Corley D, et al.
JAMA Netw Open . 2024 Dec; 7(12):e2451715. PMID: 39699893
Importance: Prior studies have shown that the benefits, harms, and costs of colorectal cancer (CRC) screening at older ages are associated with a patient's sex, health, and screening history. However,...
3.
Chubak J, Ichikawa L, Merchant S, Dalmat R, Ziebell R, Jensen C, et al.
Cancer Epidemiol Biomarkers Prev . 2024 Nov; 34(2):281-289. PMID: 39585215
Background: Screening colonoscopy harm data are limited for adults ages 76 to 85 years. Methods: We conducted a retrospective cohort study of screening colonoscopies versus fecal immunochemical tests (FIT) and...
4.
Levin T, Jensen C, Udaltsova N, Burnett-Hartman A, Kamineni A, Chao C, et al.
Ann Intern Med . 2024 Nov; 177(12):1621-1629. PMID: 39531396
Background: Guidelines now recommend initiating colorectal cancer (CRC) screening at age 45 years rather than 50 years, but little is known about screening completion and yield among people aged 45...
5.
Kane K, Jensen C, Yang J, Dong H, Merchant S, Koripella P, et al.
Clin Gastroenterol Hepatol . 2024 Oct; PMID: 39368633
Background And Aims: Prior antibiotic use may be a factor in the rising incidence of colorectal cancer seen in those under 50 years of age (early-onset colorectal cancer [EOCRC]); however,...
6.
Levin T, Jensen C, Marks A, Schlessinger D, Liu V, Udaltsova N, et al.
Gastro Hep Adv . 2024 Aug; 3(5):671-683. PMID: 39165417
Background And Aims: Demand for surveillance colonoscopy can sometimes exceed capacity, such as during and following the coronavirus disease 2019 pandemic, yet no tools exist to prioritize the patients most...
7.
Doubeni C, Corley D, Jensen C, Levin T, Ghai N, Cannavale K, et al.
JAMA Netw Open . 2024 Jul; 7(7):e2423671. PMID: 39028667
Importance: The fecal immunochemical test (FIT) is widely used for colorectal cancer (CRC) screening, but evidence of its effectiveness is limited. Objective: To evaluate whether FIT screening is associated with...
8.
Kang J, Jensen C, Merchant S, Lee J
Clin Gastroenterol Hepatol . 2024 May; 22(12):2529-2531.e7. PMID: 38782174
The World Endoscopy Organization (WEO) standardized the reporting of post-colonoscopy colorectal cancers (PCCRCs), which account for 7% to 10% of colorectal cancers (CRCs). PCCRCs are diagnosed 6 to 36 months...
9.
Hahn E, Munoz-Plaza C, Jensen C, Ghai N, Pak K, Amundsen B, et al.
J Gen Intern Med . 2024 May; 39(16):3205-3216. PMID: 38771535
Background/objective: Multilevel barriers to colonoscopy after a positive fecal blood test for colorectal cancer (CRC) are well-documented. A less-explored barrier to appropriate follow-up is repeat fecal testing after a positive...
10.
Podmore C, Selby K, Jensen C, Zhao W, Weiss N, Levin T, et al.
JAMA Netw Open . 2024 Apr; 7(4):e245295. PMID: 38625704
Importance: Organized screening outreach can reduce differences in colorectal cancer (CRC) incidence and mortality between demographic subgroups. Outcomes associated with additional outreach, beyond universal outreach, are not well known. Objective:...